CD8A and neoplasm: We observed that following bortezomib treatment, tumor-infiltrating HA518-526-specific CD8+T cells showed an enhanced expression of IL-2Rα, IL-2Rβ and IL-2Rγ compared to tumor-infiltrating CD8+T cells without bortezomib treatment (Figure 8A-8C).